Millions More Americans May Be Classified as Obese Soon

Millions More Americans May Be Classified as Obese Soon
The obesity situation in the United States may be more severe than previously thought. A new study published in JAMA Network Open reveals that incorporating waist size into the obesity definition could push U.S. obesity rates from 42.9% up to 68.6%.

I mean, that’s quite a jump. Around one in four adults may have “hidden” obesity due to excess belly fat, even while having a normal BMI. Interestingly, older adults and Asian participants experienced the most significant increases in their obesity classifications.

BOSTON — This new framework for defining obesity could significantly impact medical practices, according to research that analyzed health data from over 300,000 individuals in the U.S. By adopting guidelines endorsed by 76 professional medical organizations, scientists found that the update dramatically increased obesity rates among participants. This is largely because it accounts for individuals with unhealthy belly fat, even if they maintain what was once considered a healthy overall weight.

The study, which draws from the All of Us research program, is notable for being one of the largest examinations of how new definitions of obesity would affect health care outcomes. The researchers followed participants for four years, focusing on real health outcomes rather than just theoretical classifications.

### The Role of Waist Size

Instead of relying only on the traditional height-to-weight ratio, this new method includes metrics like waist circumference, waist-to-hip ratio, and waist-to-height ratio alongside BMI for a more nuanced health assessment. Dr. Lindsay Fourman and her team at Massachusetts General Hospital found that standard BMI measurements overlook many individuals who have harmful fat distribution patterns, particularly around the belly. They pinpointed that belly fat is a significant indicator of metabolic issues, which is often missed by just looking at weight.

They even identified a category called “anthropometric-only obesity,” affecting 78,047 participants who had a normal BMI but elevated waist measurements. Among these, a striking 22.3% were previously considered normal or underweight.

### Health Risks Overlooked by BMI

The researchers also examined who developed serious health complications. Those with this lesser-known type of obesity had substantially higher risks for various health issues compared to those without obesity, despite appearing healthy by standard measurements.

Individuals with waist-focused obesity were at a 76% greater risk of organ problems. They also had more than double the chances of developing diabetes and faced a 55% increased risk of heart disease. Other issues like high blood pressure and sleep apnea often arose slowly, suggesting that early identification through waist measurements could be crucial for preventive care.

### Age and Demographic Trends

The findings were particularly notable across different demographics. For participants aged 18 to 29, the obesity prevalence under this new definition climbed to 43.9%. For older adults, particularly those over 70, the figure soared to 78.3%. This increase likely reflects how body fat distribution tends to shift as people age, with more fat accumulating around the midsection. Among seniors, 54.4% exhibited what researchers dubbed “clinical obesity,” which indicates organ dysfunction or physical limitations.

The study also highlighted differences by race and gender, with Asian participants experiencing the most significant relative rise in obesity rates—jumping from 27.0% to 51.4% under the new criteria. Male participants were more likely than females to have this anthropometric-only classification, affecting 32.5% of men compared to 21.7% of women.

### Shifts in Treatment Guidelines

The implications of these findings could profoundly alter the landscape of obesity treatment. Currently, 44.7% of study participants fit the criteria for anti-obesity medications based on BMI guidelines. However, under the new definitions, approximately half of those who currently qualify for weight-loss medication could be considered as having preclinical or no obesity, which might affect their priority for treatment.

Moreover, among those with clinical obesity who don’t already qualify for certain medications, 22.2% wouldn’t meet the current criteria for recent clinical trials or FDA-approved treatments. This suggests a need for significant revisions in treatment guidelines.

The new framework introduces two categories: “clinical obesity,” associated with health complications, and “preclinical obesity,” which indicates early warning signs without severe symptoms yet present. This differentiation is essential since those with clinical obesity face the most considerable future health risks.

The study showed that 36% of participants had clinical obesity, with rates increasing significantly with age. Even preclinical obesity posed serious health risks, tripling the likelihood of diabetes and increasing heart disease risks by 40% compared to non-obese individuals.

For healthcare providers and insurers, these changes could have substantial financial implications. Coverage policies may need to be reassessed as the eligible population for obesity treatments shifts.

“I think we always suspected we had an obesity epidemic, but these numbers are staggering,” Dr. Fourman remarked. “With potentially 70% of adults now considered to have excess fat, we really need to rethink treatment priorities.”

While implementing this new definition will likely demand more resources than traditional BMI screenings, its potential to improve health risk identification could be worth the effort. The study’s findings align closely with CDC estimates, suggesting broad applicability to American adults.

### Summary of Research

The research involved data from 301,026 adults in the All of Us program, gathered between May 2017 and September 2023. Participants’ height, weight, waist, and hip circumferences were measured, along with health surveys. The study tracked health outcomes over a median follow-up of four years.

Results indicated that under the new definition, 68.6% of participants met the criteria for obesity, significantly higher than the 42.9% based on traditional BMI. The increase was primarily due to the inclusion of those with “anthropometric-only obesity.” Clinical obesity affected 36.1% of individuals.

### Limitations

Researchers noted that the reliance on diagnostic codes and surveys might not fully capture every case of organ dysfunction, and could not confirm direct causation between obesity and said dysfunction. Instead, the analysis focused on using the new definition’s ability to predict health risks as a key measure of its utility.

### Funding and Credibility

This study was funded by several organizations, including the National Institutes of Health and the American Heart Association. While the lead author disclosed some financial connections to pharmaceutical companies, the rigor of the research speaks to its credibility.

Publication Information: “Implications of a New Obesity Definition Among the All of Us Cohort” was published in JAMA Network Open on October 15, 2025, involving researchers from Massachusetts General Hospital and Harvard Medical School, among others.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News